Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy

被引:39
作者
Christ, M [1 ]
Klima, T [1 ]
Grimm, W [1 ]
Mueller, HH [1 ]
Maisch, B [1 ]
机构
[1] Univ Marburg, Klin Innere Med Kardiol & Intensivmed, D-35033 Marburg, Germany
关键词
cholesterol; chronic heart failure; dilated cardiomyopathy; risk stratification;
D O I
10.1093/eurheartj/ehi195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Previous studies indicate that low cholesterol levels are associated with adverse prognosis in heart failure patients, because elevated lipoprotein levels may negate bacterial endotoxin load induced by gastrointestinal congestion. Methods and results We examined the prognostic significance of lipid levels in a cohort of 422 patients with idiopathic dilated cardiomyopathy (iDCM) [50 +/- 12 years, 342 males, 80 females, left ventricular ejection fraction (LV-EF): 31.6 +/- 10.6%]. During 42 months of follow-up, 86 patients (20.3%) died or received a heart transplant. In univariate Cox regression analysis, reduced LV-EF, high New York Heart Association (NYHA) class, and increased LV end-diastolic diameter (LVEDD) were strong risk factors associated with that endpoint, whereas decreased total cholesterol, HDL-cholesterol, and apoprotein I levels were identified as weak risk predictors. After step-wise multivariable analysis, only LVEDD, NYHA class, and LV-EF emerged as parameters independently contributing to the model predicting risk for death or heart transplantation (P < 0.05). Cholesterol levels were positively associated with LV-EF and negatively associated with LVEDD (P < 0.05). Circulating sCD14 levels, a marker of endotoxin exposure, were related to cholesterol levels (P < 0.05) and LV-EF (P < 0.05). Conclusion Decreased cholesterol levels do not independently predict adverse prognosis in patients with iDCM. Our findings indicate that low cholesterol levels are dependent on the severity of cardiac disease.
引用
收藏
页码:691 / 699
页数:9
相关论文
共 51 条
[1]  
Anker SD, 1999, Z KARDIOL, V88, P18
[2]   Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[3]   Elevated soluble CD 14 receptors and altered cytokines in chronic heart failure [J].
Anker, SD ;
Egerer, KR ;
Volk, HD ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (10) :1426-&
[4]   Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy -: The cardiomyopathy trial (CAT) [J].
Bänsch, D ;
Antz, M ;
Boczor, S ;
Volkmer, M ;
Tebbenjohanns, J ;
Seidl, K ;
Block, M ;
Gietzen, F ;
Berger, J ;
Kuck, KH .
CIRCULATION, 2002, 105 (12) :1453-1458
[5]   Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction [J].
Bauersachs, J ;
Galuppo, P ;
Fraccarollo, D ;
Christ, M ;
Ertl, G .
CIRCULATION, 2001, 104 (09) :982-985
[6]   CHOLESTEROL AND MORTALITY IN NEW-ZEALAND MAORIS [J].
BEAGLEHOLE, R ;
FOULKES, MA ;
PRIOR, IAM ;
EYLES, EF .
BMJ-BRITISH MEDICAL JOURNAL, 1980, 280 (6210) :285-287
[7]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[8]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[9]   Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling [J].
Cohn, JN ;
Ferrari, R ;
Sharpe, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :569-582
[10]   Association of lipoproteins with cytokines and cytokine receptors in heart failure patients - Differences between ischaemic versus idiopathic cardiomyopathy [J].
Conraads, VM ;
Bosmans, JM ;
Schuerwegh, AJ ;
De Clerck, LS ;
Bridts, CH ;
Wuyts, FL ;
Stevens, WJ ;
Vrints, CJ .
EUROPEAN HEART JOURNAL, 2003, 24 (24) :2221-2226